News / Press Releases - December 2, 2025
On 2 December 2025, EU Ministers of Health in the Employment, Social Policy, Health and Consumer Affairs Council (EPSCO) formally adopted its General Approach on the Critical Medicines Act (CMA). EUCOPE appreciates the clear distinction between measures applying to critical medicines and to medicinal products… read more
EUCOPE Resources / Press Releases - November 17, 2025
Press Release Brussels, 17 November 2025 Today, the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) published a new report titled Competitiveness of the EU Life Sciences Sector – Analysis of the impact of current and future EU legislations on the competitiveness of the EU life sciences… read more
News / Press Releases - July 9, 2025
Brussels, 9 July 2025 – The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) reckons both the EU Medical Countermeasures and Stockpiling Strategies, published today, as positive steps toward improving the EU’s preparedness for future health emergencies. In an increasingly uncertain geopolitical scenario, strengthening the EU medical… read more
News / Press Releases - July 2, 2025
Brussels, 2 July 2025 – The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) appreciates and supports the European Commission’s ambition to strengthen the EU’s healthcare ecosystem through a comprehensive EU Life Sciences Strategy. A more integrated and innovation-friendly regulatory framework is essential for the EU to… read more
News / Press Releases - June 5, 2025
Brussels, 5 June 2025 – Following the negotiators in the Council having agreed their General Approach yesterday (4 June), the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) acknowledges the step forward in the legislative process and urges EU policymakers to safeguard the EU’s innovation-driven life sciences… read more
News / Press Releases - April 16, 2025
16 April 2025, Geneva – The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), representing the innovative pharmaceutical industry worldwide, and the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), representing small and mid-sized innovative health technology companies in Europe, welcome and echo the Call… read more
News / Press Releases - December 4, 2024
ARM, EFPIA, EUCOPE, EuropaBio, Vaccines Europe From 12 January 2025 the Regulation (EU) 2021/2282 on health technology assessment will apply and the first Joint Clinical Assessments (JCA) will be performed to assess the relative clinical effectiveness of new innovative cancer therapies and cell and gene… read more
News / Press Releases - November 27, 2024
A new college of Commissioners All signs point towards the need for a more competitive environment for pharmaceutical R&D in Europe. In this context, EUCOPE extends its congratulations to the newly appointed European Commissioners, whose mandates will deliver on large-scale change initiated under the last… read more
News / Press Releases - November 15, 2024
Brussels, 15 November 2023 Today, EUCOPE and FTI Consulting EU published a report titled The Economic Lens: Understanding What Makes the EU Attractive for Life Sciences Investments. The report provides an analysis of the current environment in the EU for attracting life sciences investments and… read more
News / Press Releases - September 24, 2024
On Tuesday 24 September, Alexander Natz, Secretary General of the European Confederation of Pharmaceuticals Entrepreneurs (EUCOPE), sent a letter to the President of the European Commission Ursula von der Leyen, President of the European Parliament Roberta Metsola, and President of the European Council Charles Michel,… read more
You are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information